Today, a coalition of organizations sent a letter to Maryland Governor Hogan objecting to a bill that gives the State’s Attorney General additional authority over competitive generic drug pricing — drugs that are typically 80% lower than their name brand counterparts. The letter is signed by American Consumer Institute, Consumer Action for a Strong Economy, FreedomWorks, Frontiers of Freedom, Independent Women’s Voice, Institute for Liberty, National Center for Public Policy Research and the Latino Coalition and is available online.
